Hill D Ashley, Furman Wayne L, Billups Catherine A, Riedley Shannon E, Cain Alvida M, Rao Bhaskar N, Pratt Charles B, Spunt Sheri L
Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA.
J Clin Oncol. 2007 Dec 20;25(36):5808-14. doi: 10.1200/JCO.2007.12.6102.
Pediatric colorectal carcinoma (CRC) is rare, but the available data suggest that it is more likely than adult CRC to be advanced at presentation and to have a poor outcome. We sought to better characterize pediatric CRC.
We reviewed the clinical and pathologic features, prognostic factors, and outcome of CRC in 77 children and adolescents (ages 7 to 19 years) referred to St Jude Children's Research Hospital between 1964 and 2003.
At presentation, 76 patients had one or more signs or symptoms of CRC (abdominal pain, altered bowel habits, weight loss, anemia). Tumors were evenly distributed between the right and left colon; 62% were mucinous adenocarcinoma. At presentation, 86% of patients had advanced-stage disease; more than half had distant metastases. Overall outcome was poor. Advanced stage and mucinous histology were significant predictors of adverse outcome. Stage-specific survival at 10 years was 67% +/- 27% (stage 1), 38% +/- 15% (stage 2), 28% +/- 11% (stage III), and 7% +/- 4% (stage 4). Although no patient had a diagnosis of polyposis syndrome before diagnosis of CRC, 17 (22%) had colon polyps and eight (including two who previously underwent pelvic radiotherapy) had multiple polyps.
Initial signs and symptoms of CRC are similar in pediatric and adult patients. The strikingly higher frequency of mucinous histology suggests that the biology of CRC differs in pediatric and adult patients and may contribute to poor outcomes. Children should be included in prospective clinical trials for CRC.
小儿结直肠癌(CRC)较为罕见,但现有数据表明,与成人CRC相比,小儿CRC在就诊时更可能处于进展期且预后较差。我们试图更好地描述小儿CRC的特征。
我们回顾了1964年至2003年间转诊至圣裘德儿童研究医院的77例儿童和青少年(7至19岁)CRC的临床和病理特征、预后因素及转归。
就诊时,76例患者有一项或多项CRC的体征或症状(腹痛、排便习惯改变、体重减轻、贫血)。肿瘤在右半结肠和左半结肠分布均匀;62%为黏液腺癌。就诊时,86%的患者处于疾病进展期;超过半数有远处转移。总体预后较差。疾病进展期和黏液组织学是不良预后的重要预测因素。10年时各分期的生存率分别为67%±27%(Ⅰ期)、38%±15%(Ⅱ期)、28%±11%(Ⅲ期)和7%±4%(Ⅳ期)。虽然在CRC诊断前没有患者被诊断为息肉病综合征,但17例(22%)有结肠息肉,8例(包括2例先前接受盆腔放疗的患者)有多发息肉。
小儿和成人患者CRC的初始体征和症状相似。黏液组织学的显著高频率提示小儿和成人患者CRC的生物学特性不同,这可能导致预后不良。儿童应纳入CRC的前瞻性临床试验。